← Back to Search

Speaking Tasks for Speech

N/A

Waitlist Available

Led By Carrie Niziolek, PhD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up data were collected over 3 individual hour-long meg sessions over 3 weeks (pre-test vs. post-test compared within the same session).

Awards & highlights

Study Summary

This trial is testing how the brain processes and controls speech in healthy people in order to help those with communication disorders. 15 participants are needed for 3-4 visits lasting 2-4 hours each.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ data were collected over 3 individual hour-long meg sessions over 3 weeks (pre-test vs. post-test compared within the same session).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~data were collected over 3 individual hour-long meg sessions over 3 weeks (pre-test vs. post-test compared within the same session).

This trial's timeline: 3 weeks for screening, Varies for treatment, and data were collected over 3 individual hour-long meg sessions over 3 weeks (pre-test vs. post-test compared within the same session). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Speaking-Induced Suppression (SIS) Change, Defined as the Percent Change of SIS (the Z-score Difference in Average M100 Amplitude in the Speak Condition Compared With the Listen Condition) From Baseline to Test Phases

Trial Design

1Treatment groups

Experimental Treatment

Group I: Healthy Adult SpeakersExperimental Treatment3 Interventions

healthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Speaking Tasks

2021

N/A

~20

MEG/EEG

2021

N/A

~20

MRI

2009

Completed Phase 2

~1370

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,182 Previous Clinical Trials

3,167,370 Total Patients Enrolled

3 Trials studying Speech

147 Patients Enrolled for Speech

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

328 Previous Clinical Trials

178,288 Total Patients Enrolled

11 Trials studying Speech

1,374 Patients Enrolled for Speech

Carrie Niziolek, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison

3 Previous Clinical Trials

147 Total Patients Enrolled

3 Trials studying Speech

147 Patients Enrolled for Speech

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you let me know the capacity of this medical research project?

"Affirmative, according to clinicaltrials.gov this experiment is actively seeking participants. The trial was initially put up on October 19th 2021 and the most recent version went live on March 9 2022. 15 patients need to be recruited from 2 distinct medical centres."

Answered by AI

Are there any vacancies in this clinical trial for participants?

"According to clinicaltrials.gov, this medical study is open for participation; the first posting was on October 19th 2021 and most recently updated March 9th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Behavioral and Neural Responses to External Alterations of Speech Variability

2021. "Behavioral and Neural Responses to External Alterations of Speech Variability". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05286658.